Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Clinical trial NCT01440101 · COMPLETED

Trial details

NCT number: NCT01440101
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2010-11-01
Primary completion: 2012-08-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.